Supplementary Methods from Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer
Satoshi Yoda,Jessica J. Lin,Michael S. Lawrence,Benjamin J. Burke, Luc Friboulet,Adam Langenbucher,Leila Dardaei,Kylie Prutisto-Chang,Ibiayi Dagogo-Jack,Sergei Timofeevski,Harper Hubbeling,Justin F. Gainor,Lorin A. Ferris,Amanda K. Riley,Krystina E. Kattermann,Daria Timonina, Rebecca S. Heist, A. John Iafrate,Cyril H. Benes,Jochen K. Lennerz,Mari Mino-Kenudson, Jeffrey A. Engelman,Ted W. Johnson,Aaron N. Hata,Alice T. Shaw crossref（2023）
AI 理解论文
溯源树
样例
